GH Research PLC

GHRS chart

GH Research PLC news

• Total non-current assets of GH Research Plc – MUN:1KA

  TradingView · Oct 24, 1:29 PM EDT

• GH Research PLC Estimates – NASDAQ:GHRS

  TradingView · Oct 23, 12:47 PM EDT

• GH Research Remains Undervalued Ahead Of Pivotal Phase III Program (NASDAQ:GHRS)

  Seeking Alpha · Oct 23, 11:45 AM EDT

• Discipline and Rules-Based Execution in GHRS Response

  Stock Traders Daily · Oct 22, 8:58 AM EDT

• GH Research (GHRS) Stock May Look Stretched As Book Value Trails Price

  Yahoo Finance · Oct 18, 6:07 PM EDT

• Postpartum Depression Market to Evolve During the Forecast Period (2026-2036) with Breakthrough Treatments and Expanding Pipeline Assets | DelveInsight

  Yahoo Finance · Aug 25, 10:31 AM EDT

• GH Research Reports Second Quarter 2026 Financial Results and Provides Business Update

  Yahoo Finance · Aug 6, 7:00 AM EDT

• Is GH Research (GHRS) Trading At A Premium To Fair Value?

  Yahoo Finance · Aug 2, 2:09 PM EDT

• CMPS, MDGL, DFTX, GHRS, HELP Stocks In Spotlight Today – Why Wells Fargo Thinks Next Wave Of Depression Drugs Could Create New Winners

  stocktwits.com · Jul 27, 10:38 AM EDT

• Eli Lilly Buys Psychedelics Maker Atai Beckley for $2.8 Billion to Develop DMT-Like Depression Drug

  247wallst.com · Jul 16, 1:53 PM EDT

• Why Psychedelic stocks are surging today

  Yahoo Finance · Jul 16, 7:44 AM EDT

• GH Research gains on optimism surrounding potential Eli Lilly-Atai deal (GHRS)

  investorshub.advfn.com · Jul 16, 6:33 AM EDT

GH Research PLC key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-K6-K2026-10-09
• 6-KReport (foreign issuer)2026-09-11
• 6-K6-K2026-08-06
• 6-K6-K2026-06-26
• 6-K6-K2026-06-04
• 6-K6-K2026-05-21
• 6-K6-K2026-05-14
• 6-K6-K2026-05-14
• 6-K6-K2026-05-13
• 6-K6-K2026-05-13
• 6-K6-K2026-04-30
• 6-K6-K2026-03-25

About GH Research PLC

Ticker

GHRS (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Dublin 2, Ireland

Incorporated in

Ireland

Fiscal year end

December 31

SEC CIK

1855129

Frequently asked questions